Abcellera Biologics Inc (ABCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 27,643 | 202,741 | 207,908 | 9,362 | 11,228 |
| Gross Profit | 27,643 | 202,741 | 207,908 | 9,362 | 11,228 |
| Operating Expenses | 34,676 | 44,667 | 47,133 | 11,130 | 12,082 |
| Operating Income | -7,033 | 158,074 | 160,775 | -1,768 | -854 |
| Interest Expense | 0 | 0 | 6,811 | 0 | 0 |
| Other Income | 4,960 | 3,413 | 1,952 | -925 | 7,557 |
| Pre-tax Income | -2,073 | 161,487 | 155,916 | -2,693 | 6,703 |
| Income Tax | 250 | 44,266 | 38,915 | N/A | N/A |
| Net Income Continuous | -2,323 | 117,221 | 117,001 | -2,693 | 6,703 |
| Net Income | $-2,323 | $117,221 | $117,001 | $-2,693 | $6,703 |
| EPS Basic Total Ops | -0.01 | 0.43 | 0.53 | -0.02 | 0.03 |
| EPS Basic Continuous Ops | -0.01 | 0.43 | 0.73 | -0.02 | 0.04 |
| EPS Diluted Total Ops | -0.01 | 0.37 | 0.45 | -0.02 | 0.03 |
| EPS Diluted Continuous Ops | -0.01 | 0.37 | 0.46 | -0.02 | 0.03 |
| EBITDA(a) | $-2,818 | $162,040 | $164,213 | $-831 | $226 |